CG Oncology Inc. (CGON) vs Merit Medical Systems, Inc. (MMSI)
A side-by-side comparison of CG Oncology Inc. and Merit Medical Systems, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGON
CG Oncology Inc.
$66.11HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
MMSI
Merit Medical Systems, Inc.
$85.05HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
Total return — CGON vs MMSI
growth of $100 · dividends reinvested · last 3yCGON +84.9% (+22.7%/yr)MMSI +7.6% (+2.5%/yr)CGON compounded faster over this window
CGON MMSI
CGON vs MMSI: by the numbers
- •CGON is the larger company ($5.83B vs $5.08B market cap).
- •MMSI is profitable (9.22% net margin) while CGON runs a net loss (-3602.68%).
Metrics side by side
Valuation
| Metric | CGON | MMSI |
|---|---|---|
| P/E ratio | N/A | 35.14 |
| Forward P/E | N/A | 19.77 |
| P/S ratio | 936.27 | 3.22 |
| P/B ratio | 5.67 | 3.02 |
| EV / EBITDA | N/A | 16.16 |
| FCF yield | N/A | 4.01% |
Profitability
| Metric | CGON | MMSI |
|---|---|---|
| Gross margin | -15.02% | 49.52% |
| Operating margin | -4722.13% | 12.75% |
| Net margin | -3602.68% | 9.22% |
| ROE | -21.80% | 8.67% |
| ROIC | -24.33% | 5.80% |
Growth (annualized)
| Metric | CGON | MMSI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 8.90% |
| FCF CAGR (5Y) | N/A | 8.96% |
| Total return CAGR (5Y) | N/A | 3.88% |
Frequently asked
- Is CGON or MMSI more profitable?
- MMSI runs the higher net margin — CGON at -3602.68% versus MMSI at 9.22%.
Go deeper
Dig into the metrics
Merit Medical Systems P/E ratioCG Oncology ROEMerit Medical Systems ROECG Oncology operating marginMerit Medical Systems operating marginCG Oncology revenue growthMerit Medical Systems revenue growthCG Oncology free cash flowMerit Medical Systems free cash flow
CG Oncology & Merit Medical Systems appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.